NCT07431073 2026-02-24
METAREM
UNICANCER
Phase 2 Not yet recruiting
Clinical Trials
22 trialsNCT07378761 2026-01-30
CHILURSO
University Hospital, Montpellier
Phase 2 Not yet recruiting
NCT07356791 2026-01-21
REBIRTH-013
RenJi Hospital
Phase 2 Not yet recruiting
NCT07346196 2026-01-20
A Trial of Locoregionally Advanced Squamous Cell Carcinoma of The Head and Neck
University of Chicago
Phase 2 Not yet recruiting
NCT07346209 2026-01-16
STRIPe
University of California, San Diego
Phase 2 Not yet recruiting
NCT07126561 2026-01-08
Trastuzumab Deruxtecan to Treat HER2 + Newly Diagnosed Metastatic GI Cancers
University of Chicago
Phase 2 Not yet recruiting
NCT07279532 2025-12-12
Clinical Study of Adjuvant Surufatinib Therapy for Postoperative High-risk Neuroendocrine Tumors Based on the Ninth Edition of the AJCC Staging System
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 2 Not yet recruiting
NCT07257380 2025-12-02
MRD-ATLAS
Shanghai Zhongshan Hospital
Phase 2 Not yet recruiting
NCT04181463 2025-10-31
Nasal Inhalation of Isopropyl Alcohol for the Treatment of Nausea in Patients With Cancer
M.D. Anderson Cancer Center
Phase 2 Not yet recruiting
NCT07142200 2025-08-26
DECIDING
RenJi Hospital
Phase 2 Not yet recruiting
NCT07077564 2025-07-22
SKB264-II-NEN
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 2 Not yet recruiting
NCT07041788 2025-06-27
Iparomlimab and Tuvonralimab Combined With SFRT and Definitive Chemoradiotherapy in Locoregionally Advanced Bulky HNSCC
Second Affiliated Hospital of Nanchang University
Phase 2 Not yet recruiting
NCT06936748 2025-06-17
SFRT+Sequential Hypofractionated/Conventional Fractionated RT+Iparomlimab and Tuvonralimab for Relapsed/Refractory Solid Tumors
Second Affiliated Hospital of Nanchang University
Phase 2 Not yet recruiting
NCT07002502 2025-06-10
Immune Modulation With PRaG-1 Treatment
Second Affiliated Hospital of Soochow University
Phase 2 Not yet recruiting
NCT06904300 2025-06-05
Ivonescimab (AK112) Plus Paclitaxel as Second-line Therapy in Patients With Advanced G/GEJ Cancer
Sun Yat-sen University
Phase 2 Not yet recruiting
NCT06942767 2025-04-27
Combination of QLS31905, QL2107 and Chemotherapy as First-line Therapy in CLDN18.2-positive Unresectable Locally Advanced or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
Qilu Pharmaceutical Co., Ltd.
Phase 2 Not yet recruiting
NCT06891521 2025-03-24
Electroacupuncture for Preventing Adverse Events of Cancer Immunotherapy
Qinghai Red Cross Hospital
Phase 2 Not yet recruiting
NCT06593548 2024-09-19
Lvosidenib (AK112) Combined With CapeOX and Radiotherapy in Patients With Unresectable Metastatic MSS-type Colorectal Cancer
Fudan University
Phase 2 Not yet recruiting
NCT06495515 2024-07-10
Efficacy and Safety of Dalpiciclib Plus Toremifene in the Treatment of Advanced First-line HR Positive and HER2 Negative Breast Cancer: a Multicenter, Single Arm, Exploratory Phase II Clinical Study
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Not yet recruiting
NCT06152523 2023-11-30
MONAMI
Assistance Publique - Hôpitaux de Paris
Phase 2 Not yet recruiting
NCT06112041 2023-11-01
The Prospective Clinical Study of Precision PRaG Therapy in Elderly Patients With Advanced Solid Malignant Tumors (PRaG9.0)
Second Affiliated Hospital of Soochow University
Phase 2 Not yet recruiting
NCT05754801 2023-03-09
Yunzhi Essence to Improve the Quality of Life of Patients With Advanced Stage of Cancer
Chinese University of Hong Kong
Phase 2 Not yet recruiting